Answers are grounded in this paper and cite their sources.
Effective management of neurodegenerative disorders like schizophrenia often remains problematic owing to the challenging brain microenvironment coupled with drug delivery issues across blood-brain barrier (BBB). In view of this, the delivery of medications through nanoparticle-mediated delivery systems is gaining popularity thanks to their structural, physico-chemical and pharmacokinetic uniqueness, which in turn improves therapeutic effectiveness. Schizophrenia remains an unaddressed medical condition, having unprecedented incidences across the globe having restricted therapeutic options for treatment. Treatment approaches are complicated due to the complex nature of schizophrenia, which involves a variety of genetic, neurological, and environmental components. Conventional antipsychotic drugs mainly target dopaminergic pathways; however, their effectiveness varies, and they frequently have a wide range of adverse effects that make treatment difficult. As mentioned, BBB stands as the main obstacle for the sub-therapeutic concentrations of drugs delivered through routine dosage forms. The inherent challenges of the BBB make it difficult for larger molecules and many hydrophilic compounds to cross into the central nervous system. However, polymeric-lipidic nanomediated platforms are now being largely explored to solve the issue. In view of the higher lipophilic nature and transcellular delivery pathway across BBB, the presence of phospho/ sphingolipids in the formulation further adds an advantage in achieving desired brain concentration. The present review compiles recent advancements in the polymeric/lipidic nano-based modalities explored over past years for the management of schizophrenia. Additionally, important translational glitches associated with novel carriers have also been covered in a nutshell.
No takes yet. Share an insight, caveat, or question.
Muduli et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: